Repositrak, Inc. (NYSE:TRAK - Get Free Report) CEO Randall K. Fields sold 2,500 shares of the stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $22.26, for a total value of $55,650.00. Following the transaction, the chief executive officer now owns 197,000 shares of the company's stock, valued at approximately $4,385,220. The trade was a 1.25% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.
Repositrak Stock Down 0.4%
Shares of TRAK traded down $0.08 during mid-day trading on Friday, reaching $21.95. The company's stock had a trading volume of 25,175 shares, compared to its average volume of 47,349. Repositrak, Inc. has a 1-year low of $14.23 and a 1-year high of $25.01. The stock has a market cap of $401.16 million, a price-to-earnings ratio of 64.56 and a beta of 0.56.
Institutional Trading of Repositrak
A hedge fund recently raised its stake in Repositrak stock. Ellsworth Advisors LLC grew its holdings in Repositrak, Inc. (NYSE:TRAK - Free Report) by 10.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 31,289 shares of the company's stock after buying an additional 2,997 shares during the period. Ellsworth Advisors LLC owned 0.17% of Repositrak worth $634,000 at the end of the most recent quarter. 27.35% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Separately, Wall Street Zen upgraded Repositrak from a "hold" rating to a "buy" rating in a research note on Thursday, May 22nd.
Read Our Latest Stock Analysis on TRAK
About Repositrak
(
Get Free Report)
Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.
See Also
Before you consider Repositrak, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Repositrak wasn't on the list.
While Repositrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
